Literature DB >> 16815626

Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles in bladder cancer.

Lourdes Mengual1, Moisès Burset, Elisabet Ars, María José Ribal, Juan José Lozano, Belén Minana, Lauro Sumoy, Antonio Alcaraz.   

Abstract

OBJECTIVES: To determine the impact of different levels of RNA degradation on gene expression measurements and to ascertain if the gene expression profile obtained from bladder washing (BW) correlates to that obtained from the related bladder tumour (BT).
METHODS: BT and BW RNAs from the same patient were heat shocked to obtain three RNA degradation states, which were compared with intact RNAs from healthy bladders by using complementary DNA (cDNA) microarrays. All samples were amplified by means of a T3N9-based transcription method. In addition, four of the differentially expressed genes in microarrays related to bladder cancer (KRT20, IGF2, GSN, and CCL2) were analyzed in 36 tumoural and 14 control BW samples by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR).
RESULTS: A high percentage of overlapping differentially expressed genes were detected between BT arrays (85-91%) and between BW arrays (78-93%). Furthermore, the similarity between BW and BT arrays was relatively high and independent of the RNA degradation state (52-60%). Finally, expression differences for the four selected genes were confirmed in the vast majority of extended BW samples tested by qRT-PCR.
CONCLUSIONS: Our results showed that partially degraded RNA samples analyzed by cDNA microarrays yielded gene expression profiles comparable to those obtained using intact RNA. Moreover, BW RNA exhibited gene expression patterns similar to those identified in the BT, indicating that BW is an appropriate sample for studying gene expression profiles of BT using cDNA microarrays. In addition, qRT-PCR results further support the suitability of BW for gene expression profiling and its potential use for routine diagnostics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815626     DOI: 10.1016/j.eururo.2006.05.039

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  7 in total

1.  Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma.

Authors:  Michael H Chapman; Robert Tidswell; James S Dooley; Neomal S Sandanayake; Virginie Cerec; Maesha Deheragoda; Alvin J X Lee; Charles Swanton; Fausto Andreola; Stephen P Pereira
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

2.  A gene expression ratio-based diagnostic test for bladder cancer.

Authors:  Lingsheng Dong; Andrew J Bard; William G Richards; Matthew D Nitz; Dan Theodorescu; Raphael Bueno; Gavin J Gordon
Journal:  Adv Appl Bioinform Chem       Date:  2009-01-12

3.  Gene expression changes between patent and fused cranial sutures in a nonsyndromic craniosynostosis population.

Authors:  Amiee B Potter; Jennifer L Rhodes; Rafael A Vega; Thomas Ridder; Rita Shiang
Journal:  Eplasty       Date:  2015-04-10

4.  Predicting Ovarian Cancer Patients' Clinical Response to Platinum-Based Chemotherapy by Their Tumor Proteomic Signatures.

Authors:  Kun-Hsing Yu; Douglas A Levine; Hui Zhang; Daniel W Chan; Zhen Zhang; Michael Snyder
Journal:  J Proteome Res       Date:  2016-07-08       Impact factor: 4.466

5.  Quality assessment and data handling methods for Affymetrix Gene 1.0 ST arrays with variable RNA integrity.

Authors:  Katie S Viljoen; Jonathan M Blackburn
Journal:  BMC Genomics       Date:  2013-01-16       Impact factor: 3.969

6.  Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays.

Authors:  Lourdes Mengual; Moisès Burset; Mercedes Marín-Aguilera; María José Ribal; Antonio Alcaraz
Journal:  BMC Res Notes       Date:  2008-06-05

7.  Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors.

Authors:  Laura A Pop; Valentina Pileczki; Roxana M Cojocneanu-Petric; Bogdan Petrut; Cornelia Braicu; Ancuta M Jurj; Rares Buiga; Patriciu Achimas-Cadariu; Ioana Berindan-Neagoe
Journal:  Onco Targets Ther       Date:  2016-06-02       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.